NCJ Number
253033
Date Published
February 2019
Length
8 pages
Annotation
Information and data are presented for Tennessee's prescription drug monitoring program, named the Controlled Substances Monitoring Database (CSMD), which is administered by the Tennessee Department of Health Board of Pharmacy.
Abstract
The CSMD email address is provided, along with website addresses for the home page, enrollment, queries, and data upload. Contact information is presented for the CSMD Director and Clinical Application Coordinator. Data for 2017 cover the state population (6,782,564), DEA registered prescribers (34,898), and DEA registered dispensers (1,758). CSMD available reports are listed. CSMD funding for 2018 came from licensing fees. Staff numbers for 2018 cover the following job categories: operational (5), technical (1), analytical (1), and "other" (0). Significant dates for the CSMD pertain to enabling legislation (January 2003), becoming operational (December 2006), initial user access (January 2007), on-line access (January 2007), and electronic reporting (December 2006). Source information is provided for statutes and rules relevant to CSMD policies and procedures. Reporting frequency for monitored drugs is 1 business day, even if no monitored drugs were prescribed or dispensed. Monitored drugs are controlled substances in schedules II, III, IV, and V. Reporting is also required for naloxone administrations, opioid-related overdoses or deaths, patient lock-in information, and drug manufacturers' or distributors' data. The CSMD also has the authority to monitor other substances, namely Gabapentine (as of July 2018). Miscellaneous capabilities and policies are listed. Enrollment in and use of the CSMD is required for both prescribers and dispensers of prescription drugs. Before law enforcement agencies can access patient drug-use information in the CSMD, they must have an active investigation of the patient or show a proper need. Data-retention policy is for 1 year. Training in the use of the CSMD is neither required nor available. Technological capabilities are reported, along with reports authorized for production by requestor type.